West Pharmaceutical Services, Inc. WST

370.44 (3.16) (0.85%) as of 25 Sep
Market cap
$26.3B
P/E
47.1×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

West Pharmaceutical Services, Inc. (WST) Current ratio

West Pharmaceutical Services, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 2.8×, down 0.2× from fiscal 2025 (3.0×). Over the past ten years it has ranged from 2.1× (fiscal 2015) to 3.7× (fiscal 2022); the current reading is higher than 73% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Annual

Period Current ratio Change
FY2025 3.0× 8.09%
FY2024 2.8× (3.05%)
FY2023 2.9× (22.07%)
FY2022 3.7× 26.13%
FY2021 2.9× 7.45%
FY2020 2.7× (11.95%)
FY2019 3.1× (1.69%)
FY2018 3.2× 18.51%
FY2017 2.7× (0.13%)
FY2016 2.7× 24.26%

Quarterly

Period Current ratio Change
Jun 2026 2.8× 4.12%
Mar 2026 2.7× (10.27%)
Dec 2025 3.0× 5.27%
Sep 2025 2.9× 3.21%
42 more quarters

Against its own ten years

Low 2.1× High 3.7×
Ten-year median 2.9×
Current reading's percentile 73

Current ratio against peers

Company Current ratio
RGEN Repligen Corporation compare 9.1×
MDLN Medline Inc. compare 4.3×
RMD ResMed Inc. compare 3.1×
WST West Pharmaceutical Services, Inc. 2.8×
ALC Alcon compare 2.1×
BAX Baxter International Inc. compare 1.9×
COO The Cooper Companies, Inc. compare 1.2×
SOLV Solventum Corporation compare 1.0×
BDX Becton, Dickinson and Company compare 0.9×
Medical Instruments & Supplies industry median 2.5×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on WST